Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Amphenol Corporation (APH)?

Page 1 of 2

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an individual investor’s stock selection process, as it may offer great insights of how the brightest minds of the finance industry feel about specific stocks. After all, these people have access to smartest analysts and expensive data/information sources that individual investors can’t match. So should one consider investing in Amphenol Corporation (NYSE:APH)? The smart money sentiment can provide an answer to this question.

Is Amphenol Corporation  going to take off soon? Money managers are getting more optimistic. The number of bullish hedge fund bets moved up by 3 in recent months. APH was in 26 hedge funds’ portfolios at the end of the third quarter of 2015. There were 23 hedge funds in our database with APH holdings at the end of the previous quarter. At the end of this article we will also compare APH to other stocks including Campbell Soup Company (NYSE:CPB), NetEase, Inc (ADR) (NASDAQ:NTES), and Endo Health Solutions Inc (NASDAQ:ENDP) to get a better sense of its popularity.

Follow Amphenol Corp (NYSE:APH)
Trade (NYSE:APH) Now!

Keeping this in mind, we’re going to review the fresh action regarding Amphenol Corporation (NYSE:APH).

Hedge fund activity in Amphenol Corporation (NYSE:APH)

At Q3’s end, a total of 26 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 13% from the previous quarter. With hedgies’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Select Equity Group, managed by Robert Joseph Caruso, holds the number one position in Amphenol Corporation (NYSE:APH). Select Equity Group has a $224.9 million position in the stock, comprising 2.1% of its 13F portfolio. The second largest stake is held by Ken Griffin of Citadel Investment Group, with a $41.3 million position; the fund has less than 0.1% of its 13F portfolio invested in the stock. Some other hedge funds and institutional investors with similar optimism contain David Harding’s Winton Capital Management, Phill Gross and Robert Atchinson’s Adage Capital Management and Jim Simons’s Renaissance Technologies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!